ATEM Structural Discovery developed a machine learning-based algorithm that transforms cryo-EM LNP images into quantitative morphological insights, delivering results within two weeks.
Public source
Publisher name
Public post
𝗜𝘀 𝗺𝗮𝗻𝘂𝗮𝗹 𝗰𝗿𝘆𝗼-𝗘𝗠 𝗶𝗺𝗮𝗴𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝘀𝗹𝗼𝘄𝗶𝗻𝗴 𝗱𝗼𝘄𝗻 𝘆𝗼𝘂𝗿 𝗟𝗡𝗣 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵? 🔬 In early R&D and exploratory formulation studies…
Company
ATEM Structural Discovery
Cryo-EM for biologics. Decision-ready results, fast.
- Industry
- Biotechnology Research
- Location
- Remscheid, DE
- Company size
- 11–50 employees
About ATEM Structural Discovery
ATEM is a specialist cryo-EM CRO working exclusively in biologics development. We answer the specific structural and morphological questions that block pharma and biotech teams from advancing their programs — delivering panel-ready, decision-ready results at the speed development timelines demand. Our work spans three active product areas: * LNP characterization, where AI-enabled morphological analysis translates particle population data into formulation and process development decisions. * High-Throughput 3D Epitope Mapping, where structure determination of antibody-antigen complexes — including membrane protein targets — delivers mechanistic interpretation and actionable design recommendations for antibody engineering and discovery biology teams. * GMP Viral Contamination Testing, where morphological analytical assays under GMP conditions produce regulatory-defensible evidence for IND, BLA, and cell bank qualification submissions. Unlike generalist analytical providers, ATEM scopes every engagement to the question being asked — not the broadest analysis that can be justified. The deliverable is always the same: a clear answer to the client's development question, documented for regulatory or internal use, and interpreted in language the development team can act on directly. To find out more about ATEM, visit www.atem.bio
See moreLatest activity
Latest activity from ATEM Structural Discovery
5 signals
Research & Knowledge
ATEM Structural Discovery reported a standard deviation of 0.7 nm when repeating the analysis across three operators.
Research & Knowledge
ATEM Structural Discovery reported a coefficient of variation across three replicates under 1% for repeatability.
Research & Knowledge
ATEM Structural Discovery reported a 99% confidence interval narrowed to 0.92 nm for particle count and sampling precision around the estimated mean diameter.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Cytiva
Cytiva introduced the NxGen scale-ready cartridge 12 L/h, designed with GMP in mind, to help maintain the same LNP workflow on the NanoAssemblr Ignite+ system as your program advances.
Products & Services
Xelari, Inc.
Xelari, Inc. delivered a de novo aptamer design task within 24 hours.
Products & Services
Omios Biologics
Omios Biologics created the computational, AI-enabled infrastructure ODE, the Omios Discovery Engine, translating viral logics into computational language and actionable targets.
Products & Services
Sable Bio
Sable Bio rebuilt its AI workflows to ensure every finding traces straight back to its source, eliminating black boxes and guesswork
Products & Services
EMIT Imaging